Novavax
NVAX
NVAX
405 hedge funds and large institutions have $8.41B invested in Novavax in 2021 Q2 according to their latest regulatory filings, with 101 funds opening new positions, 134 increasing their positions, 108 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3.96% less ownership
Funds ownership: 57.58% → 53.62% (-4%)
12% less call options, than puts
Call options by funds: $1.09B | Put options by funds: $1.23B
Holders
405
Holding in Top 10
6
Calls
$1.09B
Puts
$1.23B
Top Buyers
| 1 | +$165M | |
| 2 | +$69.4M | |
| 3 | +$60.1M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$53.4M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$40M |
Top Sellers
| 1 | -$206M | |
| 2 | -$195M | |
| 3 | -$122M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$93.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$91.9M |